ITUS Corporation ITUS
At closeJun 28, 2019, 6:07 PM EDT
Day range unavailable
- Market cap
- 86.75M
- Revenue (ttm)
- 1.11M
- EPS (ttm)
- -0.621
- Shares out
- 18.70M
- Avg volume
- 163.55K
- 52-week range
- 2.27 – 6.43
- Beta
- 1.07
- Price target
- 1.12
Key statistics
- Enterprise value
- 84.43M
- PEG ratio
- 0.00
- Price / sales
- 77.98
- Price / book
- 13.73
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -175.08K
- Total cash
- 5.34M
- Total debt
- 0
- Return on equity
- -182.59%
- Short % of float
- 10.61%
- 50-day average
- 4.64
- 200-day average
- 3.64
Analyst view
Next earnings
Consensus EPS estimate 0.00.
About ITUS Corporation
ITUS Corporation develops, acquires, and licenses emerging technologies in the areas of biotechnology. The company develops Cchek, a platform for non-invasive blood tests for the early detection of various cancers, including breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, and prostate cancer. It also develops immuno-therapy drugs for the treatment of cancer. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. ITUS Corporation was founded in 1982 and is based in San Jose, California.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- ITUScorp.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ITUS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| HERMS HENRY P | Chief Financial Officer | Conversion of Exercise of derivative security | Oct 19, 2016 | 23,321 |
| JOHNSON BRUCE F | Director | Stock Award(Grant) | Sep 21, 2017 | 604,817 |
| MONAHAN JOHN J | Director | Stock Award(Grant) | Sep 21, 2017 | 50,000 |
| TITTERTON LEWIS H JR | Director | Conversion of Exercise of derivative security | Oct 18, 2017 | 834,544 |
| WILLIAMS RICHARD H | Director | Sale | Apr 8, 2018 | 25,000 |